SEC Comment Letter 0000000000-25-003838 to VOLITIONRX LTD (VNRX)
VOLITIONRX LTD
Date: April 10, 2025 · CIK: 0000093314 · Accession: 0000000000-25-003838
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286401
Letter
Re: VolitionRx Limited Registration Statement on Form S-1 Filed April 4, 2025 File No. 333-286401 Dear Cameron Reynolds:
April 10, 2025
Cameron Reynolds Chief Executive Officer VolitionRx Limited 1489 West Warm Springs Road, Suite 110 Henderson, NV 89014
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Marc G. Alcser, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 10, 2025 Cameron Reynolds Chief Executive Officer VolitionRx Limited 1489 West Warm Springs Road, Suite 110 Henderson, NV 89014 Re: VolitionRx Limited Registration Statement on Form S-1 Filed April 4, 2025 File No. 333-286401 Dear Cameron Reynolds: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Marc G. Alcser, Esq. </TEXT> </DOCUMENT>